Cognetivity Neurosciences Ltd. operates as a technology company. The firm engages in the development of platforms for medical uses such as early detection and monitoring of cognitive impairment in neurodegenerative diseases. It uses visual stimulus based diagnostic test and artificial intelligence tools, such as Integrated Cognitive Assessment. The company was founded by Sina Habibi and Seyed-Mahdi Khaligh-Razavi on December 11, 2015 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Cognetivity Neurosciences Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cognetivity Neurosciences Ltd market cap is $895,886.00.
What is the 52-week high for Cognetivity Neurosciences Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cognetivity Neurosciences Ltd 52 week high is $0.01 as of October 10, 2025.
What is the 52-week low for Cognetivity Neurosciences Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cognetivity Neurosciences Ltd 52 week low is $0.00 as of October 10, 2025.
What was Cognetivity Neurosciences Ltd stock price yesterday?
Cognetivity Neurosciences Ltd stock price yesterday was $0.0001.
What is the 50-day moving average of Cognetivity Neurosciences Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cognetivity Neurosciences Ltd 50-day moving average is $0.00.